| WZ4002 |
WZ4002 |
1213269-23-8 |
| 2-Azabicyclo[2.2.1]heptane-2-carboxylic acid, 3-(6-broMo-1H-benziMidazol-2-yl)-, 1,1-diMethylethyl ester,(1R,3S,4S)- |
(1R,3S,4S)-3-(6-溴-1H-苯并咪唑-2-基)-2-氮杂双环[2.2.1]庚烷-2-羧酸叔丁酯 |
1256387-74-2 |
| ledipasvir interMediate |
(1R,3S,4S)-3-[6-(4,4,5,5-四甲基-1,3,2-二氧杂环戊硼烷-2-基)-1H-苯并咪唑-2-基]-2-氮杂双环[2.2.1]庚烷-2-羧酸叔丁酯 |
1256387-87-7 |
| CAL-101 |
CAL-101 |
1146702-54-6 |
| Vilazodone Hydrochloride |
盐酸维拉唑酮 |
163521-08-2 |
| 2-(2H-1,2,3-TRIAZOL-2-YL)-5-METHYLBENZOIC ACID |
5-甲基-2-(2H-1,2,3-三唑-2-基)苯甲酸 |
956317-36-5 |
| Nivolumab |
纳武单抗 |
946414-94-4 |
| 4-(2-(4-MorpholinophenylaMino)pyriMidin-4-yl)benzoic acid |
4-(2-(4-吗啉苯基氨基)嘧啶-4-基)苯甲酸 |
945749-71-3 |
| Decernotinib |
迪西替尼 |
944842-54-0 |
| 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)pyridin-2-amine |
2-氨基-4-三氟甲基-5-吡啶硼酸哪醇酯 |
944401-57-4 |
| BKM120 (NVP-BKM120, Buparlisib) |
BKM-120 |
944396-07-0 |
| Ruxolitinib |
鲁索利替尼 |
941678-49-5 |
| LCZ696 |
LCZ696 |
936623-90-4 |
| PACRITINIB |
帕克替尼 |
937272-79-2 |
| Lumacaftor (VX-809) |
鲁玛卡托 |
936727-05-8 |
| BIBF-1120 |
BIBF-1120 |
928326-83-4 |
| XL-518 raceMate |
1-[[3,4-二氟-2-[(2-氟-4-碘苯基)氨基]苯基]羰基]-3-(哌啶-2-基)氮杂环丁-3-醇 |
934662-91-6 |
| Canagliflozin heMihydrate |
卡格列净半水合物 |
928672-86-0 |
| Methyl 5-aMino-4-fluoro-1-Methyl-1H-benzo[d]iMidazole-6-carboxylate |
BINIMETINIB中间体1 |
918321-20-7 |
| Dovitinib |
多韦替尼 |
915769-50-5 |
